Clinical Trials Finder
Independent ClinicalTrials.gov directory
ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

ClinicalTrials.gov ID: NCT05850234

Public ClinicalTrials.gov record NCT05850234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced May 8, 2026, 4:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase Ib/II Study of AZD0120, Dual-Targeting Autologous Chimeric Antigen Receptor T-cell (CAR T) Therapy Directed Against CD19 and B-cell Maturation Antigen (BCMA) in Participants With Relapsed/Refractory Multiple Myeloma (DURGA-1)

Study identification

NCT ID
NCT05850234
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
182 participants

Conditions and interventions

Interventions

  • AZD0120 Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 19, 2023
Primary completion
Aug 30, 2027
Completion
Nov 13, 2028
Last update posted
May 5, 2026

2023 – 2028

United States locations

U.S. sites
36
U.S. states
21
U.S. cities
34
Facility City State ZIP Site status
Research Site Birmingham Alabama 35233 Recruiting
Research Site Phoenix Arizona 85054 Recruiting
Research Site La Jolla California 92037 Recruiting
Research Site Los Angeles California 90095 Recruiting
Research Site San Francisco California 94143 Recruiting
Research Site Aurora Colorado 80045 Recruiting
Research Site Denver Colorado 80218 Recruiting
Research Site Jacksonville Florida 32224 Recruiting
Research Site Miami Florida 33136 Not yet recruiting
Research Site Tampa Florida 33612 Recruiting
Research Site Atlanta Georgia 30322 Recruiting
Research Site Chicago Illinois 60637 Recruiting
Research Site Iowa City Iowa 52242 Recruiting
Research Site Boston Massachusetts 02114 Recruiting
Research Site Boston Massachusetts 02215 Recruiting
Research Site Ann Arbor Michigan 48109 Recruiting
Research Site Detroit Michigan 48202 Recruiting
Research Site Minneapolis Minnesota 55455 Not yet recruiting
Research Site Rochester Minnesota 55905 Recruiting
Research Site Omaha Nebraska 68198 Withdrawn
Research Site Hackensack New Jersey 07601 Withdrawn
Research Site Buffalo New York 14203 Not yet recruiting
Research Site New York New York 10065 Recruiting
Research Site Stony Brook New York 11794 Recruiting
Research Site Charlotte North Carolina 28204 Recruiting
Research Site Durham North Carolina 27705 Recruiting
Research Site Nashville Tennessee 37203 Recruiting
Research Site Nashville Tennessee 37232 Recruiting
Research Site Austin Texas 78704 Recruiting
Research Site Dallas Texas 75390 Recruiting
Research Site Houston Texas 77030 Recruiting
Research Site Salt Lake City Utah 84112 Not yet recruiting
Research Site Charlottesville Virginia 22908 Recruiting
Research Site Edmonds Washington 98026 Recruiting
Research Site Seattle Washington 98109 Recruiting
Research Site Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05850234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05850234 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →